JPWO2019189945A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019189945A5
JPWO2019189945A5 JP2020551599A JP2020551599A JPWO2019189945A5 JP WO2019189945 A5 JPWO2019189945 A5 JP WO2019189945A5 JP 2020551599 A JP2020551599 A JP 2020551599A JP 2020551599 A JP2020551599 A JP 2020551599A JP WO2019189945 A5 JPWO2019189945 A5 JP WO2019189945A5
Authority
JP
Japan
Prior art keywords
methyl
difluoromethoxy
group
fluoro
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020551599A
Other languages
English (en)
Japanese (ja)
Other versions
JP7279067B2 (ja
JP2021519294A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/014901 external-priority patent/WO2019189945A1/en
Publication of JP2021519294A publication Critical patent/JP2021519294A/ja
Publication of JPWO2019189945A5 publication Critical patent/JPWO2019189945A5/ja
Application granted granted Critical
Publication of JP7279067B2 publication Critical patent/JP7279067B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020551599A 2018-03-28 2019-03-27 複素環化合物及びその用途 Active JP7279067B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018062939 2018-03-28
JP2018062939 2018-03-28
PCT/JP2019/014901 WO2019189945A1 (en) 2018-03-28 2019-03-27 Heterocyclic compound and use thereof

Publications (3)

Publication Number Publication Date
JP2021519294A JP2021519294A (ja) 2021-08-10
JPWO2019189945A5 true JPWO2019189945A5 (zh) 2022-04-01
JP7279067B2 JP7279067B2 (ja) 2023-05-22

Family

ID=66397395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551599A Active JP7279067B2 (ja) 2018-03-28 2019-03-27 複素環化合物及びその用途

Country Status (16)

Country Link
US (2) US10807987B2 (zh)
EP (1) EP3774800A1 (zh)
JP (1) JP7279067B2 (zh)
KR (1) KR20200136957A (zh)
CN (1) CN111936495A (zh)
AR (1) AR115020A1 (zh)
AU (1) AU2019241765B2 (zh)
BR (1) BR112020018238A2 (zh)
CA (1) CA3100133A1 (zh)
EA (1) EA202092294A1 (zh)
IL (1) IL276912A (zh)
MA (1) MA52214A (zh)
MX (1) MX2020010148A (zh)
SG (1) SG11202008519RA (zh)
TW (1) TW202003519A (zh)
WO (1) WO2019189945A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11230541B2 (en) 2017-07-28 2022-01-25 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP3774800A1 (en) * 2018-03-28 2021-02-17 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US5252563A (en) * 1991-12-19 1993-10-12 G. D. Searle & Company 5,6,7,8-tetrahydro-imidazo[1,2-a]pyrimidine compounds for treatment of neurotoxic injury
JP3439551B2 (ja) * 1994-11-08 2003-08-25 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
EP0815134B1 (en) 1995-03-14 2002-06-05 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
PT929574E (pt) 1996-08-27 2005-11-30 Praecis Pharm Inc Moduladores da agregacao de peptidos beta-amiloides compreendendo d-aminoacidos
US6331640B1 (en) 1998-10-13 2001-12-18 Hoffmann-La Roche Inc. Diaminopropionic acid derivatives
CA2374346C (en) 1999-06-28 2010-06-22 Jordan J. N. Tang Inhibitors of memapsin 2 and use thereof
AU2002338334B8 (en) * 2001-04-03 2008-09-18 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
JP2004161716A (ja) * 2002-11-15 2004-06-10 Takeda Chem Ind Ltd Jnk阻害剤
BRPI0409241A (pt) * 2003-04-10 2006-03-28 Pfizer compostos bicìclicos como antagonistas do receptor de nr2b, composições farmacêuticas compreendendo os mesmos e seu uso
US20080234318A1 (en) 2005-08-31 2008-09-25 Kristjan Gudmundsson Chemical Compounds
WO2010091310A1 (en) * 2009-02-06 2010-08-12 Elan Pharmaceuticals, Inc. Inhibitors of jun n-terminal kinase
US8404859B2 (en) 2011-03-16 2013-03-26 Hoffmann-La Roche Inc. Thiazole and thiophene compounds
ES2581848T3 (es) * 2011-04-05 2016-09-07 Pfizer Limited Derivados de pirrolo[2,3-d]pirimidina como inhibidores de quinasas relacionadas con tropomiosina
FR2998892B1 (fr) 2012-12-04 2015-01-02 Pf Medicament Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
US9243001B2 (en) 2013-03-15 2016-01-26 Epizyme, Inc. Substituted benzene compounds
US20160031907A1 (en) 2013-03-15 2016-02-04 Epizyme, Inc. Substituted Benzene Compounds
US10202376B2 (en) 2014-12-24 2019-02-12 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6827757B2 (ja) 2016-10-11 2021-02-10 鬼怒川ゴム工業株式会社 ウエザーストリップ取付用クリップ
US11230541B2 (en) 2017-07-28 2022-01-25 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP3774800A1 (en) * 2018-03-28 2021-02-17 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
WO2020153414A1 (ja) 2019-01-24 2020-07-30 武田薬品工業株式会社 複素環化合物及びその用途
WO2020196828A1 (ja) 2019-03-28 2020-10-01 武田薬品工業株式会社 含窒素複素環化合物

Similar Documents

Publication Publication Date Title
JP2018044008A5 (zh)
JP4823914B2 (ja) Fgfr3の阻害および多発性骨髄腫の治療
JP5832647B2 (ja) がんの治療における使用のためのcdk4/6阻害剤およびpi3k阻害剤を含む併用療法
JP2021500345A5 (zh)
JP6345645B2 (ja) 横隔膜機能を向上させるための方法
AU2018346712B2 (en) P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
JP2016520117A (ja) ピラゾロピロリジン誘導体および疾患の処置におけるその使用
JP2019535728A (ja) キナーゼ阻害剤としての複素環式アミド
RU2008141761A (ru) ИНГИБИТОРЫ с-МЕТ ПРОТЕИНКИНАЗЫ
JP2017530185A5 (zh)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2013501749A5 (zh)
AU2015308522A1 (en) Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or impairment, and of neurodegenerative diseases
JP2017522340A (ja) 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのそれらの使用
EP3274344A1 (en) Formylated n-heterocyclic derivatives as fgfr4 inhibitors
JP2009500366A5 (zh)
JP2020503302A5 (zh)
JP2019505558A5 (zh)
JPWO2019189945A5 (zh)
TW202116301A (zh) 藥物組合及其用途
JP2005535560A5 (zh)
PL200537B1 (pl) Środek leczniczy do zapobiegania i leczenia schizofrenii oraz zastosowanie
JP2000513712A (ja) 複素環化合物およびその調製およびその使用
JPWO2021126731A5 (zh)
JPWO2019198692A5 (zh)